XENE xenon-pharma.com: Nilai pasar

Logo perusahaan publik Xenon (XENE)

This daily price chart for Xenon Pharmaceuticals (XENE) reflects the quotes of the epilepsy treatment developer, whose operating leverage has stalled at 3.49 due to high costs associated with late-stage trials. Management effectively raises capital and provides transparent reporting on final trial results. The firm's competitive advantage lies in developing precise ion channel inhibitors that reduce the risk of adverse reactions.

Xenon - Nilai pasar XENE (periode 04.07.2022 - 22.10.2026)

XENE (Xenon Corp): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Xenon Pharmaceuticals (XENE):
Rega saham Xenon|XENE - Rata-rata rega prakiraan|Nilai pasar Xenon Corp
Analisis fundamental perusahaan:XENE (Xenon)
Sampel barang xenon-pharma.com

Market capitalization reflects the aggregate value of all shares, allowing investors to quickly assess the scale of the business and identify pricing anomalies relative to fundamental value. By analyzing the current market value of Xenon Pharmaceuticals (XENE), one can track how the market prices in the potential of its proprietary modulators for epilepsy therapy, given the high switching costs for patients moving to alternative drugs.

Pesaing wigati

Kapitalisasi pasar BIIB (Biogen)|Neurocrine (NBIX) - Nilai pasar|RGC - Nilai pasar|AXSM (Axsome Corp) - Kapitalisasi pasar|ACAD: Kapitalisasi pasar|Nilai pasar vikingtherapeutics.com (VKTX)|Nilai pasar Supernus|Kapitalisasi pasar CPRX (Catalyst Pharma)|Kapitalisasi pasar DNLI|HRMY - Nilai pasar|Biohaven Ltd. - Biji pasar|Kapitalisasi pasar amylyx.com AMLX|TRVI - Nilai pasar|Nilai pasar PRAX (Praxis Precision Medicines Inc)|Anavex Corp (AVXL) - Nilai pasar|Nilai pasar CeriBell EEG (CBLL)|Biji pasar PRTA|Kapitalisasi pasar ALEC (Alector Therapeutics)|Kapitalisasi pasar ANNX|OMER - Nilai pasar|Nilai pasar Neurogene Corp NGNE|ACIU: Kapitalisasi pasar|VYGR - Nilai pasar|Nilai pasar neumoratx.com|Scilex (SCLX) - Nilai pasar|Kapitalisasi pasar TVGN|Biji pasar ACOG|CGTX: Nilai pasar|Nilai pasar Inhibikase Therapeutics (IKT)|SAVA: Biji pasar|Kapitalisasi pasar ASRT (Assertio)|Nilai pasar COYA|VistaGen Therapeutics Inc - Kapitalisasi pasar|OVID - Kapitalisasi pasar|Acumen Pharmaceuticals (ABOS) - Nilai pasar|cervomed.com - Nilai pasar|Nilai pasar Alterity Therapeutics Ltd.|Biji pasar Clene Nanomedicine (CLNN)|Kapitalisasi pasar PEPG|Kapitalisasi pasar jupiterneurosciences.com (JUNS)|Kapitalisasi pasar RLMD (Relmada Therapeutics)|ANVS - Biji pasar|Grace Tx - Kapitalisasi pasar|Nilai pasar Firefly Neuroscience, Inc.|KLTO (anewmeds.com) - Biji pasar|NeuroSense Therapeutics Ltd. (NRSN) - Kapitalisasi pasar|Biji pasar RVPH|MTVA (MetaVia, Inc.) - Nilai pasar|Kapitalisasi pasar NRXS|Kapitalisasi pasar heliusmedical.com|Kapitalisasi pasar PASG (Passage Bio)|NEUP - Biji pasar|Minerva Neurosciences - Kapitalisasi pasar|ATHA - Kapitalisasi pasar|Addex Therapeutics Ltd (ADXN) - Nilai pasar|ALZN (Alzamend Neuro) - Nilai pasar|Nilai pasar Cyclerion Therapeutics Inc.|Protagenic (PTIX) - Kapitalisasi pasar|Biji pasar KTTA (Pasithea Therapeutics)|cortigent.com - Kapitalisasi pasar|Kapitalisasi pasar ATXI (Avenue Therapeutics, Inc.)|Brainstorm Cell Therapeutics Inc. (BCLI) - Nilai pasar|CARA - Nilai pasar|CHRO (Chromocell) - Kapitalisasi pasar|ELYM: Kapitalisasi pasar|Nilai pasar Intra-Cellular Therapies, Inc. (ITCI)|Nilai pasar Longboard Pharmaceuticals, Inc.|Kapitalisasi pasar MRNS (Marinus Pharmaceuticals Inc)|Kapitalisasi pasar NKGN|NRBO - Nilai pasar|Sage Therapeutics, Inc. - Biji pasar|Kapitalisasi pasar synaptogen.com SNPX|TRVN - Nilai pasar|Nilai pasar VIGL (Vigil Neuroscience)|Anew Medical, Inc. (WENA) - Nilai pasar|Nilai pasar Cerevel Corp (CERE)